Hypoxia Reduces CD138 Expression and Induces an Immature and Stem Cell-Like Transcriptional Program in Myeloma Cells

International Journal of Oncology - Greece
doi 10.3892/ijo.2013.2134
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

A Multiepitope of XBP1, CD138 and CS1 Peptides Induces Myeloma-Specific Cytotoxic T Lymphocytes in T Cells of Smoldering Myeloma Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Dynamic CD138 Surface Expression Regulates Switch Between Myeloma Growth and Dissemination

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2019English

The MOC31PE Immunotoxin Reduces Cell Migration and Induces Gene Expression and Cell Death in Ovarian Cancer Cells

Journal of Ovarian Research
GynecologyOncologyObstetrics
2014English

An O2-Sensitive Glomus Cell-Stem Cell Synapse Induces Carotid Body Growth in Chronic Hypoxia

Cell
BiochemistryGeneticsMolecular Biology
2014English

Transcription Factor Six2 Induces a Stem Cell Like Phenotype in Renal Cell Carcinoma Cells

FEBS Open Bio
BiochemistryGeneticsMolecular Biology
2019English

Vascular Endothelial Growth Factor Receptor 3 Is a Novel Marker Differing CD138-positive and CD138-negative Multiple Myeloma Cells

British Journal of Haematology
Hematology
2017English

Hexamethylene Bisacetamide Induces Programmed Cell Death (Apoptosis) and Down-Regulates BCL-2 Expression in Human Myeloma Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

M 6 a Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program

Cancer Cell
Cancer ResearchOncologyCell Biology
2017English

All-Trans Retinoic Acid Reduces Cancer Stem Cell-Like Cell-Mediated Resistance to Gefitinib in NSCLC Adenocarcinoma Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy